Aortic arch pathologies
Conditions
Interventions
trial group:In-situ fenestration in TEVAR
Sponsors
Zhongshan Hospital Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years; 2. Patients who understand the objectives of this study, and are willing to sign informed consent files by themselves or their legal representatives; 3. Patients with good compliance to accomplish follow-up; 4. Life expectancy > 1 year; 5. Definitive diagnosis of aortic arch dilatation disease involving supra-arch vessels; 6. Suitable candidates for surgery with available access arteries.
Exclusion criteria
Exclusion criteria: 1. Patients who are not suitable for vascular intervention therapy; 2. Severe multi-organ failure or malignant tumor; 3. Allergic to intravascular contrast media; 4. History of myocardial infarction, TIA or stroke in the past three months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Freedom from MAE at 30 days; | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate of technology; | — |
Countries
China
Contacts
Public ContactYi Si
Zhongshan Hospital Fudan University
Outcome results
None listed